APA (7th ed.) Citation

Treluyer, J., Demeer, B., Faivre, L., Bardou, M., Boddaert, N., Kuentz, P., . . . Maruani, I. A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): The SESAM study protocol. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Treluyer, Jean-Marc, et al. A Phase II Double-blind Multicentre, Placebo-controlled Trial to Assess the Efficacy and Safety of Alpelisib (BYL719) in Paediatric and Adult Patients with Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP): The SESAM Study Protocol. BMJ Publishing Group.

MLA (9th ed.) Citation

Treluyer, Jean-Marc, et al. A Phase II Double-blind Multicentre, Placebo-controlled Trial to Assess the Efficacy and Safety of Alpelisib (BYL719) in Paediatric and Adult Patients with Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP): The SESAM Study Protocol. BMJ Publishing Group.